...
首页> 外文期刊>The Lancet >Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.
【24h】

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

机译:肥厚型梗阻性心肌病的非手术心肌减少。

获取原文
获取原文并翻译 | 示例

摘要

Surgery has been the only therapeutic option in patients with hypertrophic obstructive cardiomyopathy who are resistant to drug treatment and sequential pacemaker therapy. I describe a novel catheter-based technique that may replace surgical myocardial reduction in some patients. The technique aims at selective destruction of the hypertrophied part of the left side of the intraventricular septum. If temporary occlusion of the first major septal artery is shown to reduce the intraventricular pressure gradient significantly, absolute alcohol is injected through the inflated balloon catheter to produce a localised infarct. In the first three patients treated with this method, the size of the septal infarct was sufficient to eliminate any subaortic stenosis immediately. Clinical improvement has been maintained up to 12 months. Non-surgical reduction of the septum in hypertrophic obstructive cardiomyopathy warrants further clinical evaluation.
机译:手术一直是对药物治疗和起搏器治疗有抵抗力的肥厚性梗阻性心肌病患者的唯一治疗选择。我描述了一种基于导管的新技术,该技术可能会代替某些患者的外科手术心肌减少。该技术旨在选择性破坏心室间隔左侧的肥大部分。如果显示第一大中隔动脉的暂时性阻塞可显着降低脑室内压力梯度,则通过充气的球囊导管注入无水酒精以产生局部梗塞。在使用该方法治疗的前三名患者中,间隔梗塞的大小足以立即消除任何主动脉瓣狭窄。临床改善一直维持到12个月。肥厚性梗阻性心肌病的非手术性间隔复位值得进一步临床评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号